Takeda Pharmaceuticals has decided to wrap up the remaining Actos linked bladder cancer lawsuits. Takeda settled two more claims this week, after a two-month trial in Nevada state court. Recently, Takeda ear-marked $2.4 billion for settlements to settle thousands of personal injury and defective product liability lawsuits brought by diabetic…
After 4 years of intense Actos litigation, surrounding the link between the use of Actos and the development of bladder cancer, Takeda Pharmaceuticals is signaling the raising of the white flag, by entering into a series of settlement discussions. Serious effort are underway to try and resolve all of the…
Recently earlier this month, seventeen plaintiffs filed an Actos bladder cancer lawsuit against manufacturer Takeda Pharmaceuticals, blaming that the use of the type 2 diabetes treatment led to the diagnosis of bladder cancer. Four of the plaintiffs had died from advanced bladder cancer. The other plaintiffs have experienced recurrences of…
The U.S. District Judge overseeing the federal Actos litigation has issued orders requiring that the Court be provided with details about each of the cases filed, information about potential settlements and motions in various state courts throughout the country. There have been eight Actos Bladder Cancer trials to date across…
An Actos Bladder Cancer trial in West Virginia state court has started over allegations that Takeda Pharmaceutical Co. Ltd.’s popular diabetes drug Actos causes bladder cancer. The West Virginia trial comes shortly on the heels of a $2 million verdict in Philadelphia on October 3 over the blockbuster drug. It…
The Philadelphia jury spoke loud and clear. Takeda Pharmaceutical Co., the manufacturer of the popular diabetic medication, was ko’d by the jury, and ordered to pay more than $2 million to a plaintiff who claimed that Actos caused her bladder cancer. This was the latest Actos trial over bladder cancer…
There are several thousand lawsuits filed by folks both in state and federal courts by patients who took the prescription drug pioglitazone, sold as brand name Actos and later developed bladder cancer. Doctors prescribe Actos to treat patients with Type 2 Diabetes. Takeda Actos Bladder Cancer Verdict On April 7, 2014,…
After a record breaking pharmaceutical $9 billion jury verdict involving Actos bladder cancer lawsuit, Takeda Pharmaceuticals and Eli Lilly, Actos manufacturers, have filed for a new trial. Takeda Pharmaceuticals and Eli Lilly, claim that the massive award shows that the jury acted with “passion and prejudice”. Actos Record $9B Verdict…
The jury in federal court in Louisiana, sent a loud and clear message on Monday, in rendering a bombshell verdict. Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages. The federal court jury found they hid the cancer risks of…
After 33 grueling days of hotly contested trial testimony, the first federal Actos bladder cancer lawsuit trial has ended. The jury is scheduled to hear closing arguments on Monday and then deliberations will begin. Federal Actos Trial: The Details Terrance Allen’s trial began on February 3, as the first chosen…